Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Y-mAbs Therapeutics | YMAB | May 31, 2024 | 12.10 | +0.75 |
Yalla ADR | YALA | May 31, 2024 | 4.70 | -1.88 |
Yatra Online | YTRA | May 31, 2024 | 1.28 | -20.50 |
Yatsen ADR | YSG | May 31, 2024 | 3.40 | +0.59 |
Yelp | YELP | May 31, 2024 | 36.97 | +1.23 |
YETI | YETI | May 31, 2024 | 40.74 | +2.36 |
Yext | YEXT | May 31, 2024 | 5.05 | +1.00 |
Yield10 Bioscience | YTEN | May 31, 2024 | 5.26 | 0.00 |
Yieldshares High Income ETF | YYY | May 31, 2024 | 11.91 | +1.02 |
Yiren Digital ADR | YRD | May 31, 2024 | 4.84 | -0.62 |
York Water | YORW | May 31, 2024 | 37.04 | +2.52 |
Yoshiharu Global A | YOSH | May 31, 2024 | 3.92 | -0.89 |
Yoshitsu ADR | TKLF | May 31, 2024 | 0.25 | -2.33 |
Yotta Acquisition | YOTA | May 31, 2024 | 10.99 | +0.83 |
Yotta Acquisition Unit | YOTAU | May 31, 2024 | 11.00 | 0.00 |
Youdao A ADR | DAO | May 31, 2024 | 3.73 | -2.36 |
YPF Sociedad Anonima ADR | YPF | May 31, 2024 | 23.21 | -2.93 |
YS Biopharma | YS | May 31, 2024 | 1.02 | 0.00 |
Yum China | YUMC | May 31, 2024 | 35.76 | +0.82 |
Yum! Brands | YUM | May 31, 2024 | 137.43 | +1.92 |
Yunhong Green CTI | YHGJ | May 31, 2024 | 1.19 | +2.59 |
Yunji ADR | YJ | May 31, 2024 | 0.75 | +9.95 |
YY Group Holding | YYGH | May 31, 2024 | 1.15 | 0.00 |
Zai Lab ADR | ZLAB | May 31, 2024 | 17.78 | -2.25 |
Zalatoris II Acquisition | ZLS | May 31, 2024 | 10.94 | 0.00 |
Zapata Computing | ZPTA | May 31, 2024 | 0.85 | 0.00 |
Zapp Electric Vehicles Group | ZAPP | May 31, 2024 | 0.99 | +5.59 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | May 31, 2024 | 44.34 | +1.47 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | May 31, 2024 | 59.54 | +0.39 |
Zebra Technologies A | ZBRA | May 31, 2024 | 312.34 | -1.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.